PLCH1: A Protein Target for A Variety of Diseases (G23007)

Target Name: PLCH1

NCBI ID: G23007

PLCH1

PLCH1: A Protein Target for A Variety of Diseases

PLCH1 (Proteasome-Lysine 1) is a protein that is expressed in a variety of tissues throughout the body. It is a key player in the proteasome system, which is responsible for breaking down and removing proteins that are no longer needed. PLCH1 is also involved in the regulation of protein stability and has been shown to play a role in a variety of cellular processes, including cell signaling, DNA replication, and stress response.

Recent studies have identified PLCH1 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because PLCH1 has been shown to be involved in the development and progression of these conditions, and may be a useful target for therapeutic intervention.

One of the key reasons why PLCH1 has been identified as a potential drug target is its involvement in the regulation of protein stability. Many proteins that are synthesized in the cell need to be properly stabilized in order to function correctly, and PLCH1 is involved in this process. studies have shown that PLCH1 plays a role in the regulation of protein stability by helping to ensure that these proteins are properly folded and stable.

Another reason why PLCH1 has been identified as a potential drug target is its involvement in the regulation of protein stability. Many proteins that are synthesized in the cell need to be properly stabilized in order to function correctly, and PLCH1 is involved in this process. Studies have shown that PLCH1 plays a role in the regulation of protein stability by helping to ensure that these proteins are properly folded and stable.

In addition to its role in protein stability, PLCH1 has also been shown to be involved in the regulation of cell signaling and DNA replication. For example, one study found that PLCH1 was involved in the regulation of the protein kinase A尾, which is a hallmark of Alzheimer's disease. This suggests that PLCH1 may be a useful target for therapies that are aimed at preventing or treating Alzheimer's disease.

Another study also found that PLCH1 was involved in the regulation of DNA replication, which is important for the development and progression of cancer. This suggests that PLCH1 may be a useful target for therapies aimed at preventing or treating cancer.

In addition to its role in cell signaling and DNA replication, PLCH1 has also been shown to play a role in the regulation of stress response. For example, one study found that PLCH1 was involved in the regulation of the stress response in cells, which is important for the development and progression of stress-related diseases. This suggests that PLCH1 may be a useful target for therapies aimed at preventing or treating stress-related diseases.

Overall, PLCH1 has been shown to be involved in a variety of cellular processes that are important for the development and progression of a wide range of diseases. As a result, PLCH1 has emerged as a promising drug target for a variety of therapeutic interventions. Further research is needed to fully understand the role of PLCH1 in these processes and to develop effective therapies.

Protein Name: Phospholipase C Eta 1

Functions: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by calcium-activated phosphatidylinositol-specific phospholipase C enzymes

The "PLCH1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLCH1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets